Real-time enrollment status for this long qt syndrome (lqts) 2 clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:37 PM UTC
| NCT Number | NCT07277582 |
| Recruiting Status | Recruiting |
| Condition | Long QT Syndrome (LQTS) 2 |
| Phase | PHASE2 |
| Target Enrollment | 84 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Thryv Therapeutics, Inc. |
| Last Updated on CT.gov | September 21, 2026 (3 weeks ago) |
As of October 12, 2026: Clinical trial NCT07277582 is currently recruiting participants. This phase2 study for long qt syndrome (lqts) 2 is actively seeking new participants at 9 locations across the United States. The study is sponsored by Thryv Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07277582 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07277582 was last updated 3 weeks ago (September 21, 2026). HelloStudys verifies this status automatically.